340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
With some hard work, pluck, the right boyfriend and a bit of genetic luck, Kamala Harris has found her way onto the presidential ballot without having to secure a single primary vote. Don't tell me the American Dream is dead.
Sure, Harris is a demagogue who speaks in cringy, swirling, impenetrable platitudes. And sure, according to President Joe Biden, Harris was an identity hire. But "Morning Joe" says we're not supposed to talk about any of that. So, let's discuss her record and stated positions.
It seems like a lifetime ago that Biden named Harris his running mate. What you may not…
